Vivo: Acculi Labs partners with Vivo India to develop application for early COVID-19 detection
To capture an individual’s vital health statistics through mobile phone and for faster detection of COVID-19 symptoms, Bengaluru-based IT startup Acculi Labs has developed an application called Lyfas using Vivo smartphones. The company claims that this application can help in risk assessment of an asymptomatic individual.
Acculi Labs claims that it successfully tested the newly-developed application using two Vivo Y-series smartphones: Vivo Y11 and Vivo Y91. The technology uses Vivo smartphone processors and sensors to capture a bunch of body signals which are then analysed to detect the intensity of COVID-19.
Rupam Das, founder and CEO of Acculi Labs, said, “At a time when the entire world is struggling to combat this pandemic, our endeavor was to come up with an app that helps detect asymptomatic COVID positive individuals as well as assess the possibilities of these individuals becoming symptomatic in future. We are thankful to Vivo India for providing us with their smartphones – vivo Y11 and Y91, during our pilot phase, which helped us develop this app.”
Nipun Marya, director-Brand Strategy, Vivo India, said, “COVID-19 has pushed the boundaries of technological innovation across the globe. As a part of our Heroes Who Care initiative, we have continuously supported healthcare professionals working to fight the pandemic. Extending the same program, we are proud to have partnered with Acculi labs who have made this significant breakthrough.”